Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Ileitis D007079 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Multiple Trauma D009104 2 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Igarashi Y [Physiology of sphingosine 1-phosphate: regulation of cell motility and platelet function]. 1997 Seikagaku pmid:9431007
Sato A and Ebina K [Interaction between Asp-hemolysin-related synthetic peptides and oxidized LDL/lysophospholipids]. 2013 Seikagaku pmid:23819394
Tokumura A and Tsukatani H [Antagonists of platelet activating factor]. 1985 Seikagaku pmid:3009656
Shindou H [Lysophospholipid acyltransferase and platelet-activating factor (PAF) biosynthetic enzyme]. 2008 Seikagaku pmid:18341030
Nakayama R and Saito K [PAF and its physiological significance in normal tissue]. 1988 Seikagaku pmid:3286791
Satouchi K [Platelet activating factor (PAF)--a new chemical mediator of inflammation]. 1983 Seikagaku pmid:6350499
Shindou H [Discovery and characterization of novel lysophospholipid acyltransferases]. 2010 Seikagaku pmid:21348263
Wang R et al. [High performance thin layer chromatographic (HPTLC) determination of PAF in cerebrospinal fluid of patients with subarachnoid hemorrhage(SAH)]. 1999 Se Pu pmid:12552702
Voelkel NF et al. Nonimmunological production of leukotrienes induced by platelet-activating factor. 1982 Science pmid:7123233
Thurston G et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. 1999 Science pmid:10617467
Kornecki E and Ehrlich YH Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. 1988 Science pmid:3381103
Abisogun AO et al. The involvement of platelet activating factor in ovulation. 1989 Science pmid:2911750
Darius H et al. Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis. 1986 Science pmid:3082008
Kornecki E et al. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. 1984 Science pmid:6150550
Teruel MN and Meyer T Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module. 2002 Science pmid:11884760
Ruan CG et al. Studies on monoclonal antibodies against human platelets--a monoclonal antibody to human platelet glycoprotein I--SZ-2. 1987 Sci. Sin., Ser. B, Chem. Biol. Agric. Med. Earth Sci. pmid:3659897
Ding Z et al. Inhibitory effects of isoproterenol on PAF-induced endothelial cell permeability and morphological changes. 1996 Sci. China, C, Life Sci. pmid:8760474
Schaller MD [Sepsis syndrome: progress and therapeutic perspectives]. 1992 Schweiz Med Wochenschr pmid:1604283
Hilliquin P et al. Correlations between PAF-acether and tumor necrosis factor in rheumatoid arthritis. Influence of parenteral corticosteroids. 1995 Scand. J. Rheumatol. pmid:7777830
Dulioust A et al. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases. 1992 Scand. J. Rheumatol. pmid:1529281
Leistad L et al. Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage. 2011 Scand. J. Rheumatol. pmid:21417548
Renkonen R et al. Signal transduction during platelet-activating factor-induced lymphocyte binding to endothelial cells. 1990 Scand. J. Immunol. pmid:2159182
Morita E et al. Production of 15-hydroxyeicosatetraenoic acid by purified human eosinophils and neutrophils. 1990 Scand. J. Immunol. pmid:2125361
van der Poll T et al. Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6. 1996 Scand. J. Immunol. pmid:8560191
O'Donnell MC and Fiedel BA Histamine secretion from human leucocytes stimulated by basophil-derived platelet-activating factor. 1981 Scand. J. Immunol. pmid:6171870
Geffner JR et al. Interferon-gamma enhances PAF-acether production by stimulated human polymorphonuclear leucocytes. 1991 Scand. J. Immunol. pmid:1903211
Morita E et al. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. 1989 Scand. J. Immunol. pmid:2544988
Renkonen R et al. Lymphocyte binding to and penetration through vascular endothelium is stimulated by platelet-activating factor. 1989 Scand. J. Immunol. pmid:2602912
Lindström P et al. Rapid adhesive responses of endothelial cells and of neutrophils induced by leukotriene B4 are mediated by leucocytic adhesion protein CD18. 1990 Scand. J. Immunol. pmid:1972589
Yoshida N et al. Pathogenesis of platelet-activating factor-induced gastric mucosal damage in rats. 1989 Scand. J. Gastroenterol. Suppl. pmid:2556790
Rachmilewitz D et al. Platelet-activating factor--a possible mediator in the pathogenesis of ulcerative colitis. 1990 Scand. J. Gastroenterol. Suppl. pmid:1972295
Kingsnorth AN Platelet-activating factor. 1996 Scand. J. Gastroenterol. Suppl. pmid:8865468
Iwai A et al. Role of PAF in ischemia-reperfusion injury in the rat stomach. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595310
Binnaka T et al. Gastric mucosal damage induced in rats by intravenous administration of platelet-activating factor. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595311
Hatakeyama K et al. Platelet activating factor induced gastric damage in rats: participation of increased gastric vascular permeability. 1989 Scand. J. Gastroenterol. Suppl. pmid:2595312
Atuma C et al. Helicobacter pylori extracts reduce gastric mucosal blood flow by a nitric oxide-independent but mast cell- and platelet-activating factor receptor-dependent pathway in rats. 1999 Scand. J. Gastroenterol. pmid:10636064
Wang LS et al. Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. 2002 Scand. J. Gastroenterol. pmid:11989839
Sun Z et al. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. 2001 Scand. J. Gastroenterol. pmid:11218240
Denis MA et al. Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. 2001 Scand. J. Gastroenterol. pmid:11252412
Binnaka T et al. Gastric hemodynamic disturbance induced by hemorrhagic shock in rats. Role of platelet-activating factor. 1990 Scand. J. Gastroenterol. pmid:2359986
Gustafson C et al. Phospholipase C from Clostridium perfringens stimulates formation and release of platelet-activating factor (PAF-acether) in cultured intestinal epithelial cells (INT 407). 1991 Scand. J. Gastroenterol. pmid:1947765
Kald B et al. Phospholipase C from Clostridium perfringens stimulates acetyltransferase-dependent formation of platelet-activating factor in cultured intestinal epithelial cells (INT 407). 1994 Scand. J. Gastroenterol. pmid:8209184
Olanders K et al. Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats. 2003 Scand. J. Gastroenterol. pmid:12825870
Berstad A et al. Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats. 1988 Scand. J. Gastroenterol. pmid:3262915
Binnaka T et al. Burn-induced gastric mucosal hemodynamic disturbance in the rat. Role of platelet-activating factor. 1992 Scand. J. Gastroenterol. pmid:1561532
Palmblad J et al. Interactions between alkylglycerols and human neutrophil granulocytes. 1990 Scand. J. Clin. Lab. Invest. pmid:2168089
Jørgensen L et al. Rabbit lung macrophages stimulate platelets in vitro as observed by density-gradient centrifugation and transmission electron microscopy. 1993 Scand. J. Clin. Lab. Invest. pmid:8272758
Møller CH and Steinbrüchel DA Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery? 2003 Scand. Cardiovasc. J. pmid:12881156
Mastroroberto P et al. Elevated circulating levels of von Willebrand factor and D-dimer in patients with heart failure and mechanical prosthesis. 1996 Scand J Thorac Cardiovasc Surg pmid:8857679
Birk-Sørensen L et al. Platelet activating factor antagonism in pure skin flaps exposed to ischaemia-reperfusion injury. 1999 Scand J Plast Reconstr Surg Hand Surg pmid:10450571
Bottecchia D et al. Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation. 1984 Scand J Haematol pmid:6695148
Rylander R Role of endotoxin and glucan for the development of granulomatous disease in the lung. 1989 Sarcoidosis pmid:2623374
Teles de Araújo A et al. Surfactant modifications and lipidic mediators in occupational lung diseases. 1989 Sarcoidosis pmid:2623375
Kaminker AJ and Carreras LO [Physiopathology of thrombotic microangiopathy]. 1989 Sangre (Barc) pmid:2667170
Rotllan E et al. [Effect of PAF (platelet-activating factor) on hemostasis. Studies on endothelial cells and platelets]. 1993 Sangre (Barc) pmid:8390724
Meloni Bruneri LH and Barbieri D [Platelet aggregation after the reduction of nitro-blue tetrazolium by eosinophils]. 1985 Sangre (Barc) pmid:4071355
Zăgrean L et al. Preliminary EEG study of protective effects of Tebonin in transient global cerebral ischemia in rats. 1998 Jan-Jun Rom J Physiol pmid:11000876
Debek W et al. Luminol-chemiluminescence in free peritoneal cells in hemorrhagic shock in rats treated with PAF-receptor-antagonist BN 52021. 1995 Rocz. Akad. Med. Bialymst. pmid:8528982
Kirejczyk JK et al. Ginkgolide BN 52021 protects against hemorrhagic shock-induced renal injury in rats. 1995 Rocz. Akad. Med. Bialymst. pmid:8528996
Kirejczyk JK et al. Oxygen-derived free radicals in kidney in experimental hemorrhagic shock treated by PAF-receptor antagonist BN 52021. 1995 Rocz. Akad. Med. Bialymst. pmid:8528997
Gabryelewicz A Etiology and pathogenesis of acute pancreatitis--current view. 1995 Rocz. Akad. Med. Bialymst. pmid:8834603
Kira J [Multiple sclerosis]. 2005 Rinsho Shinkeigaku pmid:16447761
Izumi T and Shimizu T [Biological regulation with platelet activating factor--molecular cloning and signal transduction of PAF]. 1994 Rinsho Ketsueki pmid:8028185
Nagata K et al. [Thrombotic thrombocytopenic purpura (TTP) with a remission following splenectomy after the failure of antiplatelet therapy and plasmapheresis]. 1984 Rinsho Ketsueki pmid:6542941
Asada Y [Inflammatory and immune responses in arterial thrombus formation]. 2005 Rinsho Ketsueki pmid:16447700
Takahashi H et al. [Blood coagulation disorders in thrombotic thrombocytopenic purpura--with special reference to a von Willebrand factor abnormality]. 1987 Rinsho Byori pmid:3501812
Oda M et al. [Platelet-activating factor producing cell--target cell interactions]. 1989 Rinsho Byori pmid:2754814
Oura Y [The effects of platelet-activating factor (PAF) on the collagen-induced whole blood aggregation]. 1994 Rinsho Byori pmid:8107285
Maki N et al. [Analysis of platelet-activating factor and its effect on the lung]. 1993 Rinsho Byori pmid:8361018
Matsuno K et al. [Cytoplasm free calcium ions as a second messenger]. 1987 Rinsho Byori pmid:3437533
Kawamura Y et al. [A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions]. 1987 Rinsho Byori pmid:3437547
Ganbo T et al. Platelet activating factor (PAF) effects on ciliary activity of human paranasal sinus mucosa in vitro. 1991 Rhinology pmid:1947682
Ganbo T et al. Turn-over of PAF in cultures of human paranasal sinus mucosa. 1994 Rhinology pmid:7839082
Lima MC et al. Mediators of inflammation and antagonism of experimental pleurisy in the rat by fenspiride. 1988 Rhinol. Suppl. pmid:2907679
Su J et al. Natural antibodies against phosphorylcholine as potential protective factors in SLE. 2008 Rheumatology (Oxford) pmid:18522961
Tunc SE et al. Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients. 2005 Rheumatol. Int. pmid:15004723
Sperling RI Dietary omega-3 fatty acids: effects on lipid mediators of inflammation and rheumatoid arthritis. 1991 Rheum. Dis. Clin. North Am. pmid:1862246
Simmet T and Peskar BA Eicosanoids and the coronary circulation. 1986 Rev. Physiol. Biochem. Pharmacol. pmid:3520775
Brochet B et al. [Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis]. 1992 Rev. Neurol. (Paris) pmid:1439458
Romero A et al. [Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)]. 1988 Rev. Esp. Fisiol. pmid:3072620
Santos JC et al. Effect of intrarenal infusion of synthetic PAF-acether in dogs. 1988 Rev. Esp. Fisiol. pmid:3231880
Charbonneau P and Suisse A [Syndrome of multiple organ failure]. 1990 Rev Prat pmid:2263856
Massion PB and Frans A [Role of platelet activating factor and its antagonists in bronchial asthma]. 1992 Rev Pneumol Clin pmid:1384101
Santos OF et al. [Platelet activating factor in nephrology: physiopathologic and therapeutic perspectives]. 1988 Jul-Aug Rev Paul Med pmid:3076976
Leclercq M et al. [Effects of Hymenoptera stings: physiopathology and immunology according to recent literature findings]. 1985 Rev Med Liege pmid:2418479
Nechifor M [Agonists and antagonists of the platelet activating factor (PAF)]. 1989 Oct-Dec Rev Med Chir Soc Med Nat Iasi pmid:2636782
Cijevschi I and Cijevschi D [Ocular immunopathological characteristics and the involvement of the platelet-aggregation factor and the anti-PAF at the level of the eye]. 1999 Jan-Jun Rev Med Chir Soc Med Nat Iasi pmid:10756889
Nechifor M [Agonists and antagonists of the platelet activating factor (PAF). II]. 1990 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:2100870
Martin JG [Animal models of bronchial hyperreactivity]. 1994 Rev Mal Respir pmid:7515508
Ais JG et al. [The physiopathology of acute pancreatitis: the role of platelet-activating factor (PAF)]. 1992 Rev Esp Enferm Dig pmid:1547030
Fité-Mora R Torsade de pointes associated with rupatadine. 2009 Rev Esp Cardiol pmid:19268083
Egido J et al. [The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage]. 1990 Jul-Aug Rev Clin Esp pmid:2284487
Hosford D et al. Platelet-activating factor and cytokine interactions in shock. 1989 Resuscitation pmid:2555874
Gedeborg R and Wiklund L Experimental model of cardiovascular post-resuscitation syndrome--no effect of platelet activating factor antagonism. 1998 Oct-Nov Resuscitation pmid:9918458
Matheson MJ et al. Role of platelet activating factor, leukotrienes and polymorphs in the FMLP induced increase in microvascular leakage in rabbit trachea. 1997 Respirology pmid:9424405
Li HP et al. Effect of chinonin on acute hypoxic pulmonary vasoconstriction in Sprague-Dawley rats. 1998 Respirology pmid:9692515
Ruchaud-Sparagano MH et al. Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis. 2013 Respirology pmid:23730995
Gebremichael I and Leuenberger P Platelet-activating factor does not induce bronchial hyperreactivity in nonasthmatic subjects. 1992 Respiration pmid:1485002
Block LH et al. PAF-dependent phosphatidylinositol turnover in platelets: differences between asthmatics and normal individuals. 1990 Respiration pmid:2099571
Tohda Y et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. 2001 Respiration pmid:11223734